Louisiana State Employees Retirement System’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,400
Closed -$235K 1516
2022
Q2
$235K Sell
5,400
-100
-2% -$4.59K 0.01% 1462
2022
Q1
$276K Hold
5,500
0.01% 1453
2021
Q4
$280K Sell
5,500
-100
-2% -$5.18K 0.01% 1466
2021
Q3
$312K Buy
5,600
+300
+6% +$14.8K 0.01% 1441
2021
Q2
$227K Hold
5,300
0.01% 1483
2021
Q1
$221K Hold
5,300
0.01% 1478
2020
Q4
$247K Sell
5,300
-300
-5% -$14K 0.01% 1423
2020
Q3
$238K Buy
+5,600
New +$245K 0.01% 1320
2020
Q1
Sell
-3,430
Closed -$206K 1406
2019
Q4
$206K Sell
3,430
-270
-7% -$16.1K 0.01% 1358
2019
Q3
$209K Sell
3,700
-100
-3% -$5.62K 0.01% 1352
2019
Q2
$206K Buy
+3,800
New +$198K 0.01% 1361
2018
Q4
Sell
-4,900
Closed -$340K 1464
2018
Q3
$340K Buy
4,900
+1,200
+32% +$91K 0.01% 1316
2018
Q2
$280K Buy
+3,700
New +$233K 0.01% 1383
2017
Q4
Sell
-3,500
Closed -$209K 1469
2017
Q3
$209K Buy
3,500
+300
+9% +$18.1K 0.01% 1395
2017
Q2
$252K Sell
3,200
-100
-3% -$8.18K 0.01% 1344
2017
Q1
$274K Buy
3,300
+100
+3% +$7.43K 0.01% 1317
2016
Q4
$254K Sell
3,200
-300
-9% -$21.8K 0.01% 1337
2016
Q3
$245K Buy
+3,500
New +$194K 0.01% 1333

Other funds holding EGRX

Louisiana State Employees Retirement System's EGRX Position: Q3 2022 in Review

Louisiana State Employees Retirement System sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2022, closing a stake of 5,400 shares — an estimated $235K sold.

Louisiana State Employees Retirement System first reported a position in EGRX in Q3 2016 and held it in 18 quarters. The position peaked at $340K in Q3 2018. 153 funds tracked by Wall St. Rank hold EGRX as of Q3 2022.

  • Louisiana State Employees Retirement System reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 5,400 Eagle Pharmaceuticals, Inc. shares in Q3 2022, an estimated $235K.
  • Louisiana State Employees Retirement System first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2016 and held it in 18 quarters.
  • Louisiana State Employees Retirement System's Eagle Pharmaceuticals, Inc. position peaked at $340K in Q3 2018.
  • 153 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2022.

Based on Louisiana State Employees Retirement System's 13F filing for Q3 2022, filed 19 Oct 2022.